Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year
The Indian pharmaceutical industry is aiming to more than double its size to USD 120-130 billion by 2030 as it looks to ride on the back of innovation to become the healthcare custodian of the world, Indian Pharmaceutical Alliance (IPA) president and Torrent Group chairman Samir Mehta said. In the last 25 years, the Indian pharma industry has grown nearly 20 times - a market size of USD 58 billion from USD 3 billion in 1999-2000, contributing equally to domestic sales and exports today. The sector is among the top five contributors to India's trade surplus, which has grown to USD 19.5 billion from merely USD 1 billion in 1999-2000. "The journey of Indian pharma is a testament to how key policy reforms coupled with entrepreneurial spirit have nurtured the sector's growth," Mehta wrote in an article on the occasion of IPA completing 25 years. "The Indian pharmaceutical sector stands at a critical juncture as India heads toward 2047. From job creation to global trade and innovation to .
Apollo Hospitals, Vijaya Diagnostic and Narayana Hrudayalaya have given a fresh breakout on the daily scale. Charts show that these 5 healthcare related shares can rally up to 11 per cent.
At present, Puri serves on the boards of industry-leading organisations, including Tata Sons, Hindustan Unilever, and Dr. Reddy's Laboratories, further demonstrating his extensive expertise
Healthcare industry body NATHEALTH has asked the government to address systemic gaps such as acute shortage of medical specialists, escalating cancer care costs, and inadequate hospital infrastructure to meet the demands of a growing population in the upcoming union Budget. In its pre-Budget recommendations, NATHEALTH sought increasing budgetary allocations of the healthcare sector to over 2.5 per cent of GDP and asked Finance Minister Nirmala Sitharaman to address the growing burden of communicable and non-communicable diseases, compounded by long standing challenges. "The upcoming Union Budget offers an unprecedented chance to address systemic gaps such as the acute shortage of medical specialists, escalating cancer care costs, and inadequate hospital infrastructure to meet the demands of a growing population," NATHEALTH President Abhay Soi said in a statement. Soi, who is also the Chairman & Managing Director of Max Healthcare Institute Ltd, further said, "Expanding hospital ...
The man accused of fatally shooting the CEO of UnitedHealthcare is expected to be arraigned in a Manhattan court Monday on murder and terror charges in a state case that will run parallel to his federal prosecution. Luigi Mangione, 26, was formally charged last week by the Manhattan district attorney with multiple counts of murder, including murder as an act of terrorism. His initial appearance in New York State Supreme Court was preempted by federal prosecutors bringing their own charges over the shooting. The federal charges could carry the possibility of the death penalty, while the maximum sentence for the state charges are life in prison without parole. Prosecutors have said the two cases will proceed on parallel tracks, with the state charges expected to go to trial first. Authorities say Mangione gunned down Brian Thompson as he was walking to an investor conference in midtown Manhattan on the morning of Dec 4. Mangione was arrested in a Pennsylvania McDonald's after a five-
Record fundraising surpasses the previous high of Rs 9,370 cr in 2023
Japanese imaging and optical products major Canon believes that it has a good opportunity in India for its semiconductor lithography equipment required for chip fabrication, and it is in negotiations with companies setting up facilities here, said its India President and CEO Toshiaki Nomura. Though Canon did not disclose names, it said there are immense opportunities in this, as many chip manufacturers are now eying India as a new destination for semiconductor manufacturing. "A lot of Chip manufacturers are eyeing India as a new manufacturing place. We are discussing with all those chip manufacturers to give our product and service," Nomura told PTI. This is a "good opportunity for us", and the Tokyo-based group can contribute through its technology, products and services in this segment of the Indian market, he added. "We are installing the equipment for them to manufacture chips through our technology and the product. We help chip manufacturers build a strong facility in India. O
The initial share sale of Inventurus Knowledge Solutions Ltd, which provides healthcare support services, received 2.65 times subscription on the second day of bidding on Friday. The Rs 2,498-crore initial public offer (IPO) received bids for 2,74,86,778 shares against 1,03,66,780 shares on offer, according to NSE data. The Retail Individual Investors (RIIs) category got subscribed 4.24 times while the portion for non-institutional investors fetched 3.13 times subscription. Qualified Institutional Buyers (QIBs) part attracted 1.89 times subscription. Inventurus Knowledge Solutions Ltd has collected Rs 1,120 crore from anchor investors. The IPO will conclude on December 16. The price band for the offer is Rs 1,265-1,329 per share. The company's IPO is entirely an Offer For Sale (OFS) of 1.88 crore equity shares by promoters and individual shareholders, with no fresh issue component. Since the issue is completely an OFS, the company will not receive any proceeds from the IPO and th
Healthcare sector in the country is witnessing a hiring surge, with 47 per cent employers planning to recruit staff in this segment, driven by advancements in telehealth and a growing focus on preventive care services, TeamLease EdTech said on Wednesday. The surge in healthcare sector hiring is led by Delhi and Chennai as these cities witnessed highest demand for critical roles in this space. Delhi (65 per cent), Bangalore (56 per cent) and Ahmedabad (48 per cent) have emerged as key hubs for Research Associate roles, which involve conducting medical research, supporting clinical trials, and managing data. According to the report, the aging population and the prevalence of chronic illnesses continue to highlight the need for continuous healthcare support and innovative treatments. "With tech advancement, almost all sectors are undergoing massive changes, with healthcare standing out distinctively. Propelled by the pandemic, virtual consultation and remote healthcare support are the
Swedish PE firm invests $6 bn in 18 months; sells stake worth $2.4 bn
Report suggests the sector still faces sustainability issues due to profit crunch, expanding competition from large chains
In March, Galaxy Health received approval from the insurance regulator to start a health insurance business in India, taking the total number of standalone health insurers in the country to seven
HCG reported a consolidated net profit of Rs 20.68 crore in the second quarter of financial year 2025, as against Rs 10.78 crore in the same quarter of the previous year
The growth is attributed to higher occupancy rates and an increase in revenue per bed during the September quarter
The investment positions QubeHealth for its upcoming Series A round, targeting $9 million at a valuation of Rs 270 crore
Charlotte Hanneman, 45, is taking over as the CFO of the Dutch maker of medical equipment, succeeding Abhijit Bhattacharya
According to media reports, the hacker created Telegram bots to access data of 31,216,953 customers updated until July 2024, and 5,758,425 claims from the company available until early August
City-based DNA Wellness on Thursday said it will invest Rs 200 crore to set up over 100 cervical cancer screening labs across India by 2027. The company has acquired exclusive rights to conduct the DNA Ploidy Test, a diagnostic tool developed by the British Columbia Cancer Research Agency, Canada, the company said in a statement. The test, also known as CERViSure, is a quick, accurate, and non-invasive method to detect cervical cancer. DNA Wellness also announced the launch India's first CERViSure laboratory in Ahmedabad, Gujarat, which will provide easy access to cervical cancer screening facility to people. "Going forward, DNA wellness will invest Rs 200 crore to set up some 100 dedicated CERViSure laboratories across India, in a phased manner by 2027, to help the DNA Ploidy reach a maximum number of patients," the company said. "By October 2024, the company will open dedicatedlaboratories in Ahmedabad, Vadodara, Rajkot and Surat," Pathik Bhandari, Co-founder, DNA Wellness, ...
The researchers studied data from nationally representative surveys covering 35 states and union territories over 600 districts for a period of 20 years